• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穿孔素在阻止 ERBB-2(Her-2/neu)转基因雄性小鼠致癌作用中的多重作用。

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.

机构信息

Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy;

Aging Research Center, G. D'Annunzio University Foundation, 66013 Chieti, Italy;

出版信息

J Immunol. 2014 Jun 1;192(11):5434-41. doi: 10.4049/jimmunol.1301248. Epub 2014 Apr 30.

DOI:10.4049/jimmunol.1301248
PMID:24790144
Abstract

Perforin (pfp)-mediated cytotoxicity is one of the principal immunosurveillance mechanisms involved in the fight against cancer. However, its importance in spontaneous epithelial cancer is still poorly defined. In this study, we use a realistic mouse model that displays many features that are equivalent to human pathology to evaluate the role of pfp-dependent immunosurveillance by comparing tumor progression in rat ERBB-2 (neu) transgenic, pfp-proficient (neu(+)/pfp(+)) or pfp-deficient (neu(+)/pfp(-)) BALB/c male mice. Adult neu(+)/pfp(+) males developed poorly differentiated salivary carcinomas, whereas neu(+)/pfp(-) males displayed their salivary carcinomas noticeably earlier and showed zones of more highly differentiated tumor, indicating that pfp-mediated immunosurveillance is able not only to delay the growth kinetic of an aggressive epithelial tumor, but also to shape its histology. The role of pfp-mediated immunosurveillance appeared to be of even more dramatic importance against the less aggressive male mammary carcinomas. In neu(+)/pfp(+) males, the incidence of mammary carcinomas was a sporadic and late event. In contrast, in neu(+)/pfp(-) males their incidence was four-fold higher. This higher cancer incidence was associated with a 2-fold higher occurrence of persisting mammary remnants, a major risk factor for mammary cancer in male mice, and one that would appear to be due to pfp's previously unidentified involvement in male mammary gland rejection during embryogenesis. This work thus provides further proof of the complex role that the immune system plays in the body and gives new insight into the pathogenesis of epithelial tumors, demonstrating that the penetrance and malignancy of a tumor may be dramatically affected by pfp-dependent mechanisms.

摘要

穿孔素(pfp)介导的细胞毒性是参与抗癌的主要免疫监视机制之一。然而,其在自发性上皮癌中的重要性仍未得到充分定义。在这项研究中,我们使用一种现实的小鼠模型,该模型显示出许多与人类病理学等效的特征,通过比较在大鼠 ERBB-2(neu)转基因、pfp 有功能(neu(+)/pfp(+)或 pfp 缺失(neu(+)/pfp(-))BALB/c 雄性小鼠中的肿瘤进展,来评估 pfp 依赖性免疫监视的作用。成年 neu(+)/pfp(+)雄性小鼠发展为低分化唾液腺癌,而 neu(+)/pfp(-)雄性小鼠则更早地显示出唾液腺癌,并且显示出更高分化的肿瘤区域,这表明 pfp 介导的免疫监视不仅能够延迟侵袭性上皮肿瘤的生长动力学,还能够塑造其组织学。pfp 介导的免疫监视的作用对于侵袭性较低的男性乳腺肿瘤似乎更为重要。在 neu(+)/pfp(+)雄性小鼠中,乳腺肿瘤的发生率是零星的和晚期的事件。相比之下,在 neu(+)/pfp(-)雄性小鼠中,其发生率高四倍。这种更高的癌症发生率与持续存在的乳腺残余物的两倍高发生率相关,这是雄性小鼠乳腺癌的一个主要危险因素,这似乎是由于 pfp 以前未被识别的参与胚胎发生期间雄性乳腺的排斥。这项工作进一步证明了免疫系统在体内所起的复杂作用,并为上皮肿瘤的发病机制提供了新的见解,表明肿瘤的穿透性和恶性程度可能会受到 pfp 依赖机制的显著影响。

相似文献

1
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.穿孔素在阻止 ERBB-2(Her-2/neu)转基因雄性小鼠致癌作用中的多重作用。
J Immunol. 2014 Jun 1;192(11):5434-41. doi: 10.4049/jimmunol.1301248. Epub 2014 Apr 30.
2
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma.宿主穿孔素可减少肿瘤数量,但不会提高致癌基因驱动的乳腺腺癌的生存率。
Cancer Res. 2007 Jun 1;67(11):5454-60. doi: 10.1158/0008-5472.CAN-06-4084.
3
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.通过异种基因DNA疫苗接种诱导自身免疫来抑制HER-2/neu转基因小鼠的乳腺癌发展。
Cancer Res. 2005 Feb 1;65(3):1071-8.
4
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.HER-2/neu是经耐受处理的HER-2/neu转基因小鼠中的肿瘤排斥靶点。
Cancer Res. 2000 Jul 1;60(13):3569-76.
5
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.在转基因BALB/c小鼠中,针对大鼠her-2/Neu p185进行DNA疫苗接种比可移植性癌更有效地抑制致癌作用。
J Immunol. 2000 Nov 1;165(9):5133-42. doi: 10.4049/jimmunol.165.9.5133.
6
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.在转基因小鼠中,Erbb2致癌作用的免疫监视被显性调节性T细胞自身耐受性所掩盖。
Cancer Res. 2006 Aug 1;66(15):7734-40. doi: 10.1158/0008-5472.CAN-06-1432.
7
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.抗体、细胞因子和穿孔素在根除已形成的Her-2/neu癌中的非冗余作用。
J Clin Invest. 2003 Apr;111(8):1161-70. doi: 10.1172/JCI17426.
8
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.白细胞介素-15是HER2/neu驱动的乳腺癌发生的免疫监视和免疫预防所必需的。
Breast Cancer Res. 2015 May 22;17(1):70. doi: 10.1186/s13058-015-0588-x.
9
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine.通过白细胞介素12工程化的同种异体细胞疫苗对HER-2/neu转基因乳腺癌进行免疫预防。
Cancer Res. 2004 Jun 1;64(11):4001-9. doi: 10.1158/0008-5472.CAN-03-2984.
10
Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.在Her-2或neu转基因小鼠中编码自身或异源Her-2/neu的DNA疫苗的活性。
Cell Immunol. 2006 Apr;240(2):96-106. doi: 10.1016/j.cellimm.2006.07.002. Epub 2006 Aug 22.

引用本文的文献

1
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.Toll 样受体 2 促进乳腺癌的进展和化疗耐药性。
Oncoimmunology. 2022 Jun 15;11(1):2086752. doi: 10.1080/2162402X.2022.2086752. eCollection 2022.
2
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis.抗体依赖的细胞介导的细胞毒性作用(ADCC)、补体依赖的细胞毒性作用(CDC)和补体依赖的细胞吞噬作用(CDCC)在疫苗介导的抗Her2乳腺肿瘤发生保护中的作用
Biomedicines. 2022 Jan 21;10(2):230. doi: 10.3390/biomedicines10020230.
3
Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas ​.
通过DNA电穿孔对ROS1进行免疫可损害K-Ras驱动的肺腺癌。
Vaccines (Basel). 2020 Apr 6;8(2):166. doi: 10.3390/vaccines8020166.
4
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives.自然杀伤细胞介导的实体瘤中抗体依赖性细胞介导的细胞毒性:生物学证据与临床前景
Ann Transl Med. 2019 Mar;7(5):105. doi: 10.21037/atm.2019.01.42.
5
T Cells and Regulated Cell Death: Kill or Be Killed.T 细胞与调控性细胞死亡:生死抉择。
Int Rev Cell Mol Biol. 2019;342:27-71. doi: 10.1016/bs.ircmb.2018.07.004. Epub 2018 Aug 29.
6
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells.携带全长xCT DNA的牛疱疹病毒4型载体通过靶向癌症干细胞有效保护小鼠免受乳腺癌转移。
Oncoimmunology. 2018 Sep 6;7(12):e1494108. doi: 10.1080/2162402X.2018.1494108. eCollection 2018.
7
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer .一种靶向癌症干细胞上表达的表位特异性抗xCT的病毒样颗粒免疫疗法可抑制转移性癌症的进展。
Oncoimmunology. 2017 Dec 6;7(3):e1408746. doi: 10.1080/2162402X.2017.1408746. eCollection 2018.
8
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis.Morgana 介导的 IKK/NF-κB 信号通路促进乳腺癌转移。
Nat Commun. 2017 Nov 21;8(1):1636. doi: 10.1038/s41467-017-01829-1.
9
NK cells control breast cancer and related cancer stem cell hematological spread.自然杀伤细胞控制乳腺癌及相关癌症干细胞的血液扩散。
Oncoimmunology. 2017 Feb 23;6(3):e1284718. doi: 10.1080/2162402X.2017.1284718. eCollection 2017.
10
Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis.MMTV-PyMT诱导的乳腺肿瘤发生中的免疫监视与免疫编辑
Oncoimmunology. 2016 Dec 14;6(2):e1268310. doi: 10.1080/2162402X.2016.1268310. eCollection 2017.